This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news


British Pharmacological Society members elected as Academy of Medical Sciences Fellows

29 Apr 2016

Four members of the British Pharmacological Society have been elected as Fellows of the Academy of Medical Sciences.

British Pharmacological Society members elected as Fellows of the Royal Society

29 Apr 2016

Three members of the British Pharmacological Society were elected as Fellows of the Royal Society.

Research to be excluded from anti-lobbying clause

26 Apr 2016

The Department of Business, Innovation & Skills issued a response last week that it is their intention to exclude core research funders from the new anti-lobbying clause in government grants.

British Pharmacological Society comments on the UN Commission on Narcotics vote on the WHO recommendation on ketamine

16 Mar 2016

Professor David Webb, President of the British Pharmacological Society, comments on the UN Commission on Narcotic Drugs vote on the WHO recommendations on ketamine.    

Lessons need to be learned from clinical trial tragedy

16 Mar 2016

The recent death of a volunteer taking part in a clinical trial in France has major implications for the design of future clinical trials, says an editorial to be published in the next edition of the British Journal of Clinical Pharmacology. Written by experts in clinical pharmacology and toxicology from the UK and the Netherlands, the editorial also proposes several measures to try to prevent this kind of tragedy from happening again.

Some medications increase risk of blood vessel constriction in extremities

08 Mar 2016

A recent review of the medical literature has identified 12 classes of drugs and 4 main pathophysiological mechanisms that can cause a side effect whereby small arteries that supply blood to the skin constrict in response to cold, limiting blood supply. The condition is called Raynaud’s phenomenon.

Spider toxin analogue may help relieve pain

08 Mar 2016

New research from the British Journal of Pharmacology (BJP) suggests that a compound based on a spider toxin may be effective for treating pain.

British Pharmacological Society supports WISE

29 Feb 2016

The British Pharmacological Society is pleased to announce it is now a member of WISE, a campaign to promote women in science, technology, engineering and mathematics (STEM)

Research findings could lead to new treatments for chronic inflammatory pain

10 Feb 2016

New research uncovers a cascade of reactions within nerve cells that relay sensations of pain associated with inflammation. The findings, which are published in the British Journal of Pharmacology, indicate that drugs designed to curb this pathway may help relieve inflammatory pain in sufferers.  

Upcoming British Pharmacological Society prizes & awards

28 Jan 2016

The Society warmly welcomes your nominations for our many prizes and awards open this year. Over £300,000 is available each year in prizes and awards that recognise and reward the contributions of our members to pharmacology throughout their careers.

Improve early access to data from catastrophic clinical trials: A statement on behalf of the British Pharmacological Society

22 Jan 2016

In 2006, in London, six young men almost died in a private clinic after receiving an immunomodulatory drug, TGN1412, which caused severe inflammatory reactions in a first-in-man study. Earlier this month, in France, at least five men were injured (one of whom subsequently died) in a private clinic after being given an FAAH inhibitor in its first study with multiple-dosing. Thankfully, such devastating outcomes to clinical trials are extremely rare events.